会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Virtual colonoscopy with radiolabeled phospholipid ether analogs
    • 具有放射性标记的磷脂醚类似物的虚拟结肠镜检查
    • US20060013767A1
    • 2006-01-19
    • US11177749
    • 2005-07-08
    • Jamey WeichertMarc Longino
    • Jamey WeichertMarc Longino
    • A61K51/00
    • A61K51/0408A61B6/037A61B6/508
    • The present invention provides agents and methods for dual modality virtual colonoscopy that gives both anatomical and functional information using hybrid CT/PET scanning. In preferred embodiments, the present invention provides radiolabeled tumor-specific agents and methods for distinguishing benign polyps from malignant tumors. In further embodiments, the present invention provides compositions and methods useful for distinguishing morphological and functional subregions of a selected region of tissue based on relative levels of phospholipid metabolism. Preferred radiolabeled tumor-specific agents are phospholipid ether analogs labeled with a halogen radiosiotope. In certain preferred embodiments, the compositions including radiolabeled phospholipid ether analogs have therapeutic actions in addition to functionally identifying malignant tissue.
    • 本发明提供用于双重模态虚拟结肠镜检查的药剂和方法,其使用混合CT / PET扫描给出解剖和功能信息。 在优选的实施方案中,本发明提供放射性标记的肿瘤特异性试剂和用于区分良性息肉与恶性肿瘤的方法。 在另外的实施方案中,本发明提供了基于相对磷脂代谢水平来区分组织选定区域的形态学和功能亚区域的组合物和方法。 优选的放射性标记的肿瘤特异性试剂是用卤素无机物质标记的磷脂醚类似物。 在某些优选实施方案中,包括放射性标记的磷脂醚类似物的组合物除了在功能上鉴定恶性组织之外还具有治疗作用。
    • 7. 发明申请
    • VIRTUAL COLONOSCOPY WITH RADIOLABELED PHOSPHOLIPID ETHER ANALOGS
    • 具有放射性磷脂醚类似物的虚拟结构
    • US20070098633A2
    • 2007-05-03
    • US11177749
    • 2005-07-08
    • Jamey WeichertMarc Longino
    • Jamey WeichertMarc Longino
    • A61K51/00
    • A61K51/0408A61B6/037A61B6/508
    • The present invention provides agents and methods for dual modality virtual colonoscopy that gives both anatomical and functional information using hybrid CT/PET scanning. In preferred embodiments, the present invention provides radiolabeled tumor-specific agents and methods for distinguishing benign polyps from malignant tumors. In further embodiments, the present invention provides compositions and methods useful for distinguishing morphological and functional subregions of a selected region of tissue based on relative levels of phospholipid metabolism. Preferred radiolabeled tumor-specific agents are phospholipid ether analogs labeled with a halogen radioisotope. In certain preferred embodiments, the compositions including radiolabeled phospholipid ether analogs have therapeutic actions in addition to functionally identifying malignant tissue.
    • 本发明提供用于双重模态虚拟结肠镜检查的药剂和方法,其使用混合CT / PET扫描给出解剖和功能信息。 在优选的实施方案中,本发明提供放射性标记的肿瘤特异性试剂和用于区分良性息肉与恶性肿瘤的方法。 在另外的实施方案中,本发明提供了基于相对磷脂代谢水平来区分组织选定区域的形态学和功能亚区域的组合物和方法。 优选的放射性标记的肿瘤特异性试剂是用卤素放射性同位素标记的磷脂醚类似物。 在某些优选实施方案中,包括放射性标记的磷脂醚类似物的组合物除了在功能上鉴定恶性组织之外还具有治疗作用。